JENNA CASTIGLIONE: Open Payments
NPI 1487113338 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,658 in 66 payments from 18 companies in 2025. Trend: 2023 $1,257 · 2024 $969 · 2025 $1,658
Food & beverage: $1,621Consulting: $36
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $246 |
| GlaxoSmithKline, LLC. | 10 | $222 |
| Regeneron Healthcare Solutions, Inc. | 8 | $174 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $164 |
| Novartis Pharmaceuticals Corporation | 5 | $123 |
| Genentech USA, Inc. | 4 | $113 |
| GENZYME CORPORATION | 4 | $107 |
| CSL Behring | 4 | $106 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $78 |
| BioCryst US Sales Co., LLC | 3 | $70 |
Products named: DUPIXENT, AIRSUPRA, Xolair, CUVITRU, TRELEGY ELLIPTA, NUCALA, Hizentra, NEFFY.
Industry payments across AZ — which companies pay providers there.
